Page last updated: 2024-08-17

calcium acetate and Bone Diseases

calcium acetate has been researched along with Bone Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; de Oliveira, RB; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM	1
Copland, M; Komenda, P; McCullough, PA; Morfin, JA; Weinhandl, ED	1
Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB	1

Reviews

1 review(s) available for calcium acetate and Bone Diseases

Article	Year
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 68, Issue:5S1 Topics: Acetates; Bone Diseases; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis; Sevelamer	2016

Trials

2 trial(s) available for calcium acetate and Bone Diseases

Article	Year
Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:10 Topics: Acetates; Adaptor Proteins, Signal Transducing; Adiponectin; beta Catenin; Biomarkers; Bone Density; Bone Diseases; Bone Morphogenetic Proteins; Calcium Compounds; Chelating Agents; Energy Metabolism; Female; Fibroblast Growth Factor-23; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Leptin; Male; Middle Aged; Polyamines; Renal Insufficiency, Chronic; Serotonin; Sevelamer; Wnt Proteins	2013
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron. Clinical practice, 2011, Volume: 117, Issue:1 Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed	2011

Article

Year

Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:10

Topics: Acetates; Adaptor Proteins, Signal Transducing; Adiponectin; beta Catenin; Biomarkers; Bone Density; Bone Diseases; Bone Morphogenetic Proteins; Calcium Compounds; Chelating Agents; Energy Metabolism; Female; Fibroblast Growth Factor-23; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Leptin; Male; Middle Aged; Polyamines; Renal Insufficiency, Chronic; Serotonin; Sevelamer; Wnt Proteins

2013

Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.

Nephron. Clinical practice, 2011, Volume: 117, Issue:1

Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed

2011